The Thai government announced, via the Thai Khu Fah Facebook page on 20 July, that three locally produced COVID-19 vaccines will be ready for administration by next year.
The first, CU-Cov19 (mRNA), is being developed in collaboration with Chulalongkorn University’s Faculty of Medicine and the University of Pennsylvania, and is currently in the human-trial phase.
The second, HXP-GPO Vac (inactivated), is developed by the Government Pharmaceutical Organization in collaboration with Mahidol University and the United States’ PATH Institute. It is also currently in the human-trial phase.
The last one, Baiya SARS-CoV-1 Vax 1, is developed from tobacco leaves by Baiya Phytopharm and Chulalongkorn University. This vaccine has been successfully tested on animals and will soon be tried out on humans.
